InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Are generic manufacturer patents driving up drug prices?

Peter Leung, Hong Kong


A study from the University of Melbourne shows that Australia’s most expensive drugs are attached to patents not held by the innovator company

The paper, entitled "Patents Associated with High-Cost Drugs in Australia", examined 15 of the costliest drugs in Australia over the past 20 years and the patents associated with them, and found that each had an average of 49 associated patents. There...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Dieter Kuhn of DSM presents his conclusions on the doctrine of equivalents in Europe at #EULifeSciences18 https://t.co/iMfRPg2HJQ

Apr 24 2018 11:30 ·  reply ·  retweet ·  favourite
ManagingIP profile

Dieter Kuhn of DSM says “the heart and soul of doctrine of equivalents cases is language” but three of four recent… https://t.co/v0laeOkzHt

Apr 24 2018 11:08 ·  reply ·  retweet ·  favourite
ManagingIP profile

Beatrix Diaz de Escauriaza of Chemo Pharma discussing second medical use patent cases in Spain and concluding “ther… https://t.co/vysLAaOgiv

Apr 24 2018 10:56 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

April 2018

Special Report: Will blockchain revolutionise IP?

In this special report, Managing IP looks at how blockchain technology will change intellectual property. Ellie Mertens analyses the issues and opportunities it presents for patents, trade mark and copyright



Most read articles

Supplements